Call Number (LC) | Title | Results |
---|---|---|
RM301.25 .V64 2002eb | Drug discovery and evaluation : pharmacological assays / | 1 |
RM301.25 .V64 2006eb | Drug discovery and evaluation safety and pharmacokinetic assays / | 1 |
RM301.25 .W35 2013 | A Mathematical Approach to Multilevel, Multiscale Health Interventions : Pharmaceutical Industry Decline and Policy Response. | 1 |
RM301.25 .W36 2016eb | Exposure-response modeling : methods and practical implementation / | 1 |
RM301.25 .W45 2013 | International regulatory harmonization amid globalization of drug development : workshop summary / | 1 |
RM301.25 .Y66 2016eb | Tapping molecular wilderness : drugs from chemistry--biology--biodiversity interface / | 1 |
RM301.25 .Y83 2023 | Model-assisted Bayesian designs for dose finding and optimization : methods and applications / | 1 |
RM301.25 .Y84 2016i | Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry / | 1 |
RM301.25 .Z36 2020 | The science and business of drug discovery : demystifying the jargon / | 1 |
RM301.25 .Z363 2011eb | The science and business of drug discovery : demystifying the jargon / | 1 |
RM301.25 .Z44 2023 | Handbook for chemical process research and development / | 1 |
RM301.25 RM301.25.Q35 2007 | Quality Assurance of Pharmaceuticals : Good Manufacturing Practices and Inspection - A Compendium of Guidelines and Related Materials. | 1 |
RM301.27 |
Secrets of the drug trials / Innovative statistics in regulatory science / Innovative strategies, statistical solutions and simulations for modern clinical trials / The benefit/risk ratio : a handbook for the rational use of potentially hazardous drugs / CRC handbook of sample size guidelines for clinical trials / Interface between regulation and statistics in drug development / The clinical research process in the pharmaceutical industry / Clinical trials handbook design and conduct / Discussion framework for clinical trial data sharing : guiding principles, elements, and activities / Innovation in clinical trial methodologies : lessons learned during the Corona pandemic / SIGNAL DETECTION FOR MEDICAL SCIENTISTS; LIKELIHOOD RATIO TEST-BASED METHODOLOGY. The drug development paradigm in oncology : proceedings of a workshop / Human-based systems for translational research / The medicinal chemist's guide to solving ADMET challenges / Advanced statistics in regulatory critical clinical initiatives / Re-engineering clinical trials : best practices for streamlining the development process / Healthy volunteers in commercial clinical drug trials : when human beings become guinea pigs / Practical considerations for adaptive trial design and implementation / Design and analysis of subgroups with biopharmaceutical applications Phase II clinical development of new drugs / Benefit-risk assessment of medicines : the development and application of a universal framework for decision-making and effective communication / A concise guide to clinical trials / Statistics Applied to Clinical Trials Intelligent drug development : trials and errors in clinical research / Medical Product Safety Evaluation : Biological Models and Statistical Methods / Practical guide to clinical data management / Data and safety monitoring committees in clinical trials / Platform trial designs in drug development : umbrella trials and basket trials / Causal inference in pharmaceutical statistics / |
30 |
RM301.27 .A22 2010 |
The professional guinea pig Big Pharma and the risky world of human subjects / The professional guinea pig : Big Pharma and the risky world of human subjects / |
2 |
RM301.27 .A27 2003eb | Science, politics, and the pharmaceutical industry : controversy and bias in drug regulation / | 1 |
RM301.27 .A273 2000eb | Regulating medicines in Europe : competition, expertise, and public health / | 1 |
RM301.27 .A35 | Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives / | 1 |
RM301.27 .A36 2011 |
ADMET for medicinal chemists a practical guide / ADMET for medicinal chemists : a practical guide / |
2 |
RM301.27 .B45 2014 | Benefit-risk assessment in pharmaceutical research and development / | 1 |
RM301.27 .B53 2016 | Pharmaceutical research, democracy and conspiracy : international clinical trials in local medical institutions / | 1 |